After a 200% rally in less than a month, Akari Therapeutics PLC (ADR) (NASDAQ:AKTX) shares tumbled nearly 15% today. The reason?
Chardan analyst Gbola Amusa is placing his confidence behind AveXis Inc (NASDAQ:AVXS) even in light of competitors Biogen Inc (NASDAQ:BIIB) and Ionis Pharmaceuticals …
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) are currently plummeting 62% in pre-market trading after yesterday’s announcement that the biotech firm has discontinued all of its …
Analysts are offering their two cents on biotech firms Amicus Therapeutics, Inc. (NASDAQ:FOLD) and Synergy Pharmaceuticals Inc (NASDAQ:SGYP).
Chardan is divided when it comes to forecasts moving forward for biotech stocks Novavax, Inc. (NASDAQ:NVAX) and Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR).
News from Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) and bluebird bio Inc (NASDAQ:BLUE) have sent biotech investors running for the hills and have left shares …
Healthcare stocks Palatin Technologies (NYSEMKT:PTN), Novocure Ltd (NASDAQ:NVCR), and AveXis Inc (NASDAQ:AVXS) are reaping the benefits of clinical and corporate progress updates that have sent the …
In a research report released Friday, Chardan analyst Madhu Kumar reiterated a Sell rating on shares of Arbutus Biopharma Corp (NASDAQ:ABUS), after the company …
In a research report issued today, Chardan analyst Gbola Amusa maintained a Sell rating on shares of Esperion Therapeutics Inc (NASDAQ:ESPR), with a $36 price …
In a research note issued today, Chardan analyst Gbola Amusa maintained a Buy rating on shares of Uniqure NV (NASDAQ:QURE), and reduced the price target to …
